Skyrizi was the top Rx and over-the-counter (OTC) pharma brand advertising on TV in 2024, according to data released by iSpot.tv on Thursday afternoon. AbbVie’s psoriasis, ulcerative colitis, Crohn’s ...

That’s according to the latest figures by real-time ad trackers iSpot.TV, which sees the Big Pharma dig deep into its wallet as it handed over nearly $19 million more for its Skyrizi ads in Octo ...

AbbVie’s Skyrizi took home the top spot for most pharma brand ad impressions in April 2025, according to data released by iSpot.tv on Wednesday afternoon. The psoriasis treatment garnered an ...

Ads for Skyrizi, a medicine to treat plaque psoriasis and other illnesses, show patients snorkeling and riding bikes — flashing their rash-free elbows. People with Type 2 diabetes dance and sing ...

Skyrizi (risankizumab-rzaa) is a prescription injection that’s used to treat certain autoimmune disorders, such as plaque psoriasis and Crohn’s disease. Skyrizi comes in a few different forms ...